MANCINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 590
EU - Europa 355
AS - Asia 185
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.133
Nazione #
US - Stati Uniti d'America 588
IE - Irlanda 126
CN - Cina 82
SG - Singapore 68
DE - Germania 65
SE - Svezia 43
IT - Italia 42
TR - Turchia 24
UA - Ucraina 24
GB - Regno Unito 22
BE - Belgio 8
FI - Finlandia 8
CZ - Repubblica Ceca 6
ES - Italia 4
FR - Francia 4
IN - India 4
CA - Canada 2
EU - Europa 2
JP - Giappone 2
VN - Vietnam 2
BG - Bulgaria 1
IL - Israele 1
LB - Libano 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
TH - Thailandia 1
Totale 1.133
Città #
Chandler 143
Dublin 126
Jacksonville 101
Singapore 65
Ann Arbor 35
Boardman 29
New York 23
Nanjing 21
L'aquila 20
Wilmington 19
Ashburn 18
Santa Clara 17
Bremen 16
Izmir 16
Lawrence 16
Princeton 16
Woodbridge 15
Beijing 13
Grafing 11
San Mateo 11
Munich 10
Brussels 8
Houston 6
Nanchang 6
Shenyang 6
Brno 5
Des Moines 5
Jinan 5
Seattle 5
Tianjin 5
Changsha 4
Dearborn 4
Falls Church 4
Kunming 4
Hanover 3
Hebei 3
Madrid 3
Norwalk 3
Shanghai 3
Washington 3
Berlin 2
Dallas 2
Dong Ket 2
Frankfurt am Main 2
Guangzhou 2
Piombino Dese 2
Rome 2
Tokyo 2
Verona 2
Beauharnois 1
Beirut 1
Belgrade 1
Bologna 1
Carlentini 1
Casoria 1
Changchun 1
Chengdu 1
Fremont 1
Fuzhou 1
Hangzhou 1
Helsinki 1
Jiaxing 1
Lampang 1
Los Angeles 1
L’Aquila 1
Milan 1
Mountain View 1
Newark 1
Ningbo 1
Pavia 1
Phoenix 1
Pune 1
Santiago De Compostela 1
Shreveport 1
Sofia 1
Stockholm 1
Tappahannock 1
Toronto 1
Warsaw 1
Totale 874
Nome #
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 99
Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds 99
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 86
Possible involvement of SIRT1 and FOXO3a in oxidative stress response and aging of human granulosa cells 82
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 82
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 80
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 75
Possible role or SIRT 1in human ovarian granulosa cells 71
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 71
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 69
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 63
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 62
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model. 58
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 55
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 43
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 39
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 34
Totale 1.168
Categoria #
all - tutte 4.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 3 17 20 4 16 9 1 14
2020/2021130 3 13 3 17 14 5 16 3 16 7 25 8
2021/2022117 7 1 16 8 5 14 4 5 11 10 8 28
2022/2023387 22 34 3 56 34 34 0 29 150 4 9 12
2023/202498 14 2 6 7 12 36 0 4 0 1 3 13
2024/2025123 10 6 24 28 55 0 0 0 0 0 0 0
Totale 1.168